A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis Panel, General
Test CodeCPT Codes
86704, 86706, 86708, 86803, 87340
Includes
Hepatitis B Surface Antibody, Qualitative
Hepatitis B Surface Antigen with Reflex Confirmation
Hepatitis B Core Antibody, Total
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
.
Hepatitis B Surface Antigen with Reflex Confirmation: Positive samples will be confirmed based on the manufacturer's FDA approved recommendations at an additional charge (CPT code(s): 87341).
If Hepatitis C Antibody is reactive or borderline, then Hepatitis C Viral RNA, Quantitative, Real-Time PCR will be performed at an additional charge (CPT code(s): 87522).
Preferred Specimen
Minimum Volume
Other Acceptable Specimens
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Immunoassay (IA)
Setup Schedule
Clinical Significance
This panel provides information on infection and the immune response to hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV), the 3 most common causes of viral hepatitis in the United States. In patients with unexplained elevated liver enzyme levels, this panel may be helpful in evaluating etiology for these viral hepatitides [1-4].
This panel includes 5 tests with reflexes: total HAV antibody, qualitative hepatitis B surface antibody (HBsAb), hepatitis B surface antigen (HBsAg) with reflex confirmation, total hepatitis B core antibody (HBcAb), and HCV antibody with reflex to HCV RNA quantitative real-time PCR. The section below outlines the roles of the analytes assessed with this panel.
Total HAV antibody: Presence of total HAV antibody is consistent with (1) immunity due to prior infection or vaccination; or (2) current HAV infection or recent HAV vaccination [2].
Qualitative HBsAb: Presence indicates resolution of HBV infection or prior vaccination. To determine immune status due to past HBV infection or vaccination (ie, HBsAb titer ≥10 mIU/mL), a quantitative HBsAb test must be ordered [3].
HBsAg with reflex confirmation: Presence indicates that a person has a current HBV infection and is infectious [3].
Total HBcAb: Presence indicates past or current HBV infection [3].
HCV antibody with reflex to HCV RNA: Presence (with detectable HCV RNA) indicates current infection. A positive result with a "not detected" HCV RNA reflex result may indicate a resolved infection or a biological false-positive antibody screening test [4].
The results of the test in the panel should be interpreted in the context of pertinent clinical history and physical examination findings.
References
1. Viral Hepatitis Surveillance - United States, 2019. Centers for Disease Control and Prevention. Accessed January 16, 2022. https://www.cdc.gov/hepatitis/statistics/2019surveillance/pdfs/2019HepSurveillanceRpt.pdf
2. Nelson NP, et al. MMWR Recomm Rep. 2020;69(5):1-38.
3. Roush SW, et al. Chapter 22: laboratory support for surveillance of vaccine-preventable diseases. In: Roush SW, et al, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Reviewed June 3, 2021. Accessed January 16, 2022. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt22-lab-support.html
4. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 2013;62(18):362-365.